PO.IM02.04 · 免疫学

体内全基因组规模增强子筛选解码肿瘤中的T细胞命运决定

In vivo genome-scale enhancer screen decodes T cell fate decisions in the tumor

海报缩略图:体内全基因组规模增强子筛选解码肿瘤中的T细胞命运决定
编号 4258 展板 26 时间 4/21 09:00–12:00 区域 Section 6 主讲 Keely Ji, BS
分会场 Adaptive Immunity in Cancer
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Keely Y. Ji1, Alex Chang-Yu Chen1, Laura Hinojosa2, Bolutito Babatunde2, Daniela Martinez1, Thomas J. LaSalle1, Maria Zschummel1, Marc A. Schwartz1, Ferhat Ay2, Debattama Sen1

1MGH/Harvard Medical School, Boston, MA,2La Jolla Institute for Immunology, La Jolla, CA

摘要 Abstract

中文摘要
在慢性感染和癌症进展过程中,T细胞进入一种称为耗竭的功能失调状态,对疾病控制和免疫治疗结果构成重大挑战。此前,我们和其他团队已证明T细胞耗竭是一个在表观遗传水平上受调控的分化过程。耗竭T细胞在慢性感染和肿瘤中共享一个保守的染色质可及性图谱程序(核心耗竭程序),该程序在T细胞早期分化中被印记。然而,核心耗竭程序内的开放染色质区域是否以及哪些在驱动耗竭状态中发挥因果作用,仍不清楚。我们假设核心耗竭程序包含调控耗竭中T细胞持久性和分化的转录增强子,从而阻止功能的重振。为验证这一点,我们利用了我们新颖的增强子编辑平台——通过配对sgRNA进行系统性非编码元件探查(SNIP-R),这是一个基于pooled CRISPR的增强子删除平台,针对原代T细胞中千碱基规模的扰动进行了优化。我们对表达OVA的肿瘤中的卵清蛋白特异性CD8+ T细胞(OT-1)进行了首个体内全基因组规模增强子删除筛选。我们鉴定出核心耗竭程序中调控肿瘤内T细胞持久性和亚群形成的调控元件网络。来自该筛选的验证研究显示,在T细胞中删除Klf6基因上游100kb处的一个此类调控元件(Klf6-100kb)可改善肿瘤控制。Klf6-100kb被扰动的T细胞强烈优于对照群体,并且与对照扰动相比在肿瘤中产生了更多的效应样T细胞。总之,我们证明核心耗竭程序包含T细胞耗竭背后的因果调控元件,并锁定了开发下一代过继性T细胞疗法的新靶点。
查看英文原文 English abstract
During chronic infection and cancer progression, T cells enter a dysfunctional state called exhaustion, posing a significant challenge to disease control and immunotherapy outcomes. Previously, we and others have shown that T cell exhaustion is a differentiation process regulated at the epigenetic level. Exhausted T cells share a conserved program of chromatin accessibility landscapes across chronic infections and tumors (core exhaustion program) that is imprinted in early T cell differentiation. However, it remains unclear whether and which open chromatin regions within the core exhaustion program play a causal role in driving the exhausted state. We hypothesize that the core exhaustion program contains transcriptional enhancers that regulate T cell persistence and differentiation in exhaustion, preventing reinvigoration of function. To test it, we leveraged our novel enhancer editing platform called Systematic Non-coding element Interrogation by Paired sgRNAs (SNIP-R), a pooled CRISPR-based enhancer deletion platform optimized for kilobase-scale perturbation in primary T cells. We performed the first in vivo genome-scale enhancer deletion screen on ova-specific CD8 + T cells (OT-1) in OVA-expressing tumors. We identified networks of regulatory elements in the core exhaustion program that regulate T cell persistence and subset formation in the tumor. Validation studies from the screen showed that deleting one such regulatory element 100kb upstream of the Klf6 gene ( Klf6-100kb ) in T cells improved tumor control. Klf6-100kb perturbed T cells strongly outcompeted control populations and had increased generation of effector-like T cells in the tumor compared to control perturbations. Together, we showed that the core exhaustion program contains causal regulatory elements underlying T cell exhaustion and pinpointed new targets for developing next-generation adoptive T cell therapies.
利益披露 Disclosure
K. Y. Ji, None.. A. Chen, None.. L. Hinojosa, None.. B. Babatunde, None.. D. Martinez, None.. T. J. LaSalle, None.. M. Zschummel, None.. M. A. Schwartz, None.. F. Ay, None.. D. Sen, None.

← 返回 AACR 2026 检索